About

The current pandemic has reminded us the challenges and difficulties in dealing with infections and other biomedical problems. Nanomaterials have found numerous applications in the field of medicine but are not without limitations. In this panel, the emerging and advancement of new nanomaterials, nanotoxicity, and their biomanufacturing will be presented, and their roles in potential COVID-19 diagnosis, treatments, and vaccine development will be discussed. Biomaterials like peptides will be used as examples to understand and control immune responses in developing vaccines or serving as innovative new nanomaterials.

Moderators:
Bingyun Li, PhD
J. Amber Jennings, PhD